The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Arkowitz David since year 2005.
The trader's CIK number is 1296999.
At the time of the last reporting, Arkowitz David was the Chief Financial Officer of Flexion Therapeutics Inc .
(stock ticker symbol FLXN).
See this page for all insider trading activities at Flexion Therapeutics Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-05-13||FLXN||Flexion Therapeutics Inc||Buy||4,000||11.99||47,960|
|2019-05-08||FLXN||Flexion Therapeutics Inc||Sale||2,248||10.06||22,614|
|2018-11-09||FLXN||Flexion Therapeutics Inc||Buy||4,000||16.55||66,220|
|2018-08-09||FLXN||Flexion Therapeutics Inc||Buy||4,000||23.42||93,680|
|2017-08-04||SBPH||Spring Bank Pharmaceuticals, Inc.||Buy||2,500||12.24||30,612|
|2011-05-31||AMAG||Amag Pharmaceuticals Inc.||Buy||1,500||13.23||19,845|
|2011-02-24||AMAG||Amag Pharmaceuticals Inc.||Sale||2,705||17.08||46,201|
|2010-08-05||AMAG||Amag Pharmaceuticals Inc.||Sale||15,750||.00||0|
|2010-05-28||AMAG||Amag Pharmaceuticals Inc.||Buy||658||27.06||17,805|
|2009-12-01||AMAG||Amag Pharmaceuticals Inc.||Buy||172||31.78||5,466|
|2009-06-02||AMAG||Amag Pharmaceuticals Inc.||Buy||529||25.61||13,547|
|2009-11-12||AMAG||Amag Pharmaceuticals Inc.||Sale||4,459||43.41||193,587|
|2008-06-11||AMAG||Amag Pharmaceuticals Inc.||Buy||1,000||37.50||37,500|
|2007-05-05||AMAG||Amag Pharmaceuticals Inc.||Buy||1,000||40.38||40,378|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Arkowitz David (Chief Financial Officer of Flexion Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.